Description

Furo[3,2-B]Pyridin-6-Ol CAS NO 1171920-19-6 is a high-purity heterocyclic organic compound featuring a fused furan and pyridine ring system, serving as a critical advanced pharmaceutical intermediate. Its unique molecular architecture makes it a valuable building block for the synthesis of novel active pharmaceutical ingredients (APIs) and complex organic molecules. This compound is primarily utilized by research institutions and pharmaceutical companies engaged in drug discovery and development, particularly for creating potential therapeutic agents targeting the central nervous system and other disease areas.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates and active pharmaceutical ingredients (APIs).
• Medicinal Chemistry Research: Used as a core scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Organic Synthesis Building Block: Employed in the construction of complex heterocyclic compounds for agrochemical and material science applications.
• Biochemical Research: Potential use as a ligand or probe in biochemical assays and enzyme inhibition studies.
• Academic & Contract Research: Serves as a valuable reagent for synthetic methodology development and academic research in organic chemistry.

Basic Information

Product Name	Furo[3,2-B]Pyridin-6-Ol
CAS No.	1171920-19-6
Molecular Formula	C7H5NO2
Molecular Weight	135.12 g/mol
Synonyms	6-Hydroxyfuro[3,2-b]pyridine; Furo[3,2-b]pyridin-6-ol; 6-Hydroxyfuro[3,2-b]pyridine; 1171920-19-6; 6-Furo[3,2-b]pyridinol; Furo(3,2-b)pyridin-6-ol; 6-Hydroxy-1-benzofuro[3,2-b]pyridine (incorrect but common misnomer); 6-Oxofuro[3,2-b]pyridine (tautomeric form)
EINECS	Contact for details

Quality Control

Our Furo[3,2-B]Pyridin-6-Ol is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with each shipment, detailing all specification results. Our quality commitment aligns with cGMP principles for pharmaceutical intermediates, ensuring reliable supply for critical research and development applications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at a controlled room temperature (typically 15-25°C). Keep away from incompatible materials such as strong oxidizing agents. For long-term storage, consider storing under an inert atmosphere to maintain optimal stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Residual Solvents (GC)	Complies with ICH guidelines
Loss on Drying	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.